244 related articles for article (PubMed ID: 18166168)
1. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
3. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
Park JE; Lee ST; Im WS; Chu K; Kim M
Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211
[TBL] [Abstract][Full Text] [Related]
4. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
6. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid.
Dautry C; Vaufrey F; Brouillet E; Bizat N; Henry PG; Condé F; Bloch G; Hantraye P
J Cereb Blood Flow Metab; 2000 May; 20(5):789-99. PubMed ID: 10826529
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
Puerta E; Hervias I; Barros-Miñones L; Jordan J; Ricobaraza A; Cuadrado-Tejedor M; García-Osta A; Aguirre N
Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
[TBL] [Abstract][Full Text] [Related]
8. In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid.
Kraft JC; Osterhaus GL; Ortiz AN; Garris PA; Johnson MA
Neuroscience; 2009 Jul; 161(3):940-9. PubMed ID: 19362126
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
[TBL] [Abstract][Full Text] [Related]
11. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
El Massioui N; Ouary S; Chéruel F; Hantraye P; Brouillet E
Exp Neurol; 2001 Nov; 172(1):172-81. PubMed ID: 11681849
[TBL] [Abstract][Full Text] [Related]
12. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
13. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats.
Tsai RK; Chang CH; Wang HZ
Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391
[TBL] [Abstract][Full Text] [Related]
15. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
[TBL] [Abstract][Full Text] [Related]
17. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways.
Chen WF; Jean YH; Sung CS; Wu GJ; Huang SY; Ho JT; Su TM; Wen ZH
Neuroscience; 2008 Apr; 153(1):31-43. PubMed ID: 18358629
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
[TBL] [Abstract][Full Text] [Related]
20. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
